HIGHLIGHTS
- who: Gustav J. Ullenhag et al. from the Department of Radiology, Oncology and Radiation Science, Section of Oncology, University have published the Article: A Phase I Dose-Escalation Study of Lenalidomide in Combination with Gemcitabine in Patients with Advanced Pancreatic Cancer, in the Journal: Neurology 1(8) (Continued) of July/30,/2014
- what: The aim of this study was to assess the feasibility of combining lenalidomide with the standard treatment gemcitabine in patients with advanced disease. The high frequency of dermatological toxicity observed in the current trial in combination with gemcitabine, compared to lenalidomide as . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.